Labcorp, a diagnostics and laboratory company, is spinning off its clinical trials division into a separate publicly traded company.
Labcorp will house the company’s existing global laboratory business while the new company will manage clinical trials for drug companies. Management said in a release Thursday that this structure will allow each division more flexibility to grow within their individual markets.
